查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2128119

數位生物製造市場規模、佔有率、成長、全球產業分析、區域趨勢以及 2026 年至 2034 年的預測。

Digital Biomanufacturing Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 198 Pages | 商品交期: 2-3個工作天內

價格

數位生物製造市場的成長要素

2025年全球數位生物製造市場規模為224.4億美元，預計2026年將成長至251.6億美元。到2034年，該市場預計將達到661.4億美元，預測期內複合年成長率（CAGR）為12.84%。生物製藥、生物相似藥、疫苗、細胞療法和基因療法的產量增加，以及對自動化和數位化流程最佳化的需求不斷成長，是推動市場擴張的主要因素。 2025年，北美主導數位生物製造市場，佔全球41.27%的市場。

數位化生物製造透過整合自動化、連網設備、製程分析、生產執行系統 (MES)、電子批記錄 (eBR)、人工智慧和即時監控等技術，最佳化生物製藥生產。一次性技術的日益普及、外包給合約研發生產機構 (CDMO) 的趨勢以及從紙本文件向互聯數位化工作流程的轉變，持續加速著全球市場的成長。

市場趨勢

數位生物製造市場的關鍵趨勢是自動化和即時製程控制的日益普及。生物製藥製造商正在用整合數位平台取代人工生產方法，這些平台可以即時監測關鍵程式參數，例如 pH 值、溶解氧、溫度、壓力和進料速率。

SCADA 系統、分散式控制系統 (DCS)、製程分析技術 (PAT)、雲端平台和 AI 驅動的監控工具的整合，正在提高製造一致性，減少批次缺陷，並加速研發和商業生產設施之間的技術轉移。

市場促進因素

生物製藥、生物相似藥、疫苗、重組蛋白、細胞療法和基因療法的快速發展持續成長要素。與傳統製藥生產不同，生物製藥生產需要高度可控、數據密集的生產環境，並嚴格遵守相關法規。

數位化製造平台有助於減少人為錯誤、提高批次一致性、簡化監管文件、加速製程規模化，並促進跨多個製造地的技術轉移。合約研發生產機構（CDMO）和生物製藥公司對先進製造設施的持續投資，也為市場的強勁成長提供了有力支撐。

市場限制因素

高昂的實施成本仍是數位化生物製造廣泛應用面臨的主要挑戰。實施一套整合化的數位製造系統需要在自動化基礎設施、製造執行系統 (MES)、電子批次記錄、流程分析技術、網路安全、資料整合、驗證、員工培訓和持續技術支援等方面進行大量投資。

由於預算限制以及將現代平台與現有舊有系統整合的複雜性，小規模的生物技術公司和本地製造商通常分階段採用數位技術。

市場機遇

監管機構加強對先進製藥生產的支持力度，為該行業帶來了巨大的成長機會。監管機構正日益鼓勵採用自動化、數位孿生、機器人、人工智慧和即時監控技術，以提高生產的一致性和產品品質。

隨著包括細胞和基因療法在內的先進療法在商業上變得越來越擴充性，對能夠提供可擴展、經過驗證和受監管的生產環境的數位連接製造平台的需求也日益成長。

市場挑戰

生物製程工程和數位化製造技術雙料人才短缺仍然是該行業面臨的主要挑戰之一。成功實施需要自動化、人工智慧、製造執行系統 (MES)、流程分析技術、資料整合、驗證、網路安全和品管等領域的資深專業人員。

合格人員短缺導致實施成本增加、部署進度延遲，以及與數位投資相關的生產力提升效果達到速度放緩。

細分分析

就產品而言，受自動化生物反應器、互聯一次性系統和整合製造設施的大量投資推動，預計到2025年，硬體和連網設備領域將佔市場主導地位。同時，隨著企業對諮詢、驗證、系統整合和技術支援的需求日益成長，服務領域預計將實現最快成長。

按類型分類，自動化和製程控制領域佔最大的市場佔有率，因為生物製藥生產高度依賴對關鍵生產參數的持續監控和控制。人工智慧、機器學習和進階分析領域預計將在預測期內實現最高成長。

按應用領域分類，商業化GMP生產執行仍然是一個重要細分市場，因為製造商擴大採用無紙化批次記錄、自動化生產流程和符合規範的生產系統。此外，隨著企業對其生產設施進行現代化改造，技術轉移和設施數位化也在迅速發展。

按終端用戶分類，製藥和生物技術公司佔最大的市場佔有率。這主要歸功於它們在生物製藥生產能力、數位轉型和全球生產擴張方面的大量投資。此外，隨著外包業務的持續擴張，市場對契約製造組織（CMO）和研發生產管理組織（CDMO）的需求也十分強勁。

區域展望

預計到2025年，北美將引領全球數位生物製造市場，銷售額將達92.6億美元。該地區受益於其強大的生物製藥製造能力、先進的自動化技術、強力的監管支援以及數位製造平台的廣泛應用。預計到2026年，美國市場規模將達到94.2億美元，約佔全球銷售額的37.5%。

歐洲仍然是第二大市場，這得益於其完善的生物製藥生產基礎設施、日益​​普及的數位化生產系統以及有利的監管政策。

亞太地區正經歷最快的成長，預計到 2026 年將達到 57 億美元。中國、印度、日本、韓國、新加坡和澳洲的生物製藥生產、CDMO（合約開發和生產組織）能力、疫苗、生物相似藥和先進療法的快速擴張，持續推動該地區的需求。

同時，在拉丁美洲、中東和非洲，由於對藥品製造、醫療保健基礎設施和當地生物製藥生產的投資增加，市場正在穩步擴張。

目錄

第1章：引言

第2章摘要整理

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢
  • 市場挑戰

第4章：主要考慮因素

  • 主要產業趨勢（合併、收購、合作等）
  • 新產品發布：按主要公司分類
  • 概述：數位生物製造領域的投資趨勢
  • 數位生物製造領域的技術進步

第5章：2021-2034年全球數位生物製造市場分析、洞察與預測

  • 市場分析、洞察與預測：按產品/服務分類。
    • 軟體平台
    • 硬體和連接的設備
    • 服務
  • 市場分析、洞察與預測：按類型
    • 製造執行系統和電子批次記錄
    • 自動化和製程控制
    • 過程分析技術和即時監控
    • 數位孿生、建模與仿真
    • 人工智慧、機器學習和進階分析
    • 生物過程資料管理與整合
    • 品質與實驗室資訊學
    • 其他
  • 市場分析、洞察與預測：按應用領域分類
    • 製程開發和規模化
    • 商業化GMP生產執行
    • 即時製程監控與控制
    • 品管和批次放行
    • 技術轉移和設施數位化
    • 其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 製藥和生物技術公司
    • 學術研究機構
    • CMO 和 CDMO
    • 其他
  • 分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美數位生物製造市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲數位生物製造市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區數位生物製造市場分析、洞察與預測（2021-2034年）

  • 國家
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲數位生物製造市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲數位生物製造市場分析、洞察與預測（2021-2034年）

  • 國家
    • GCC
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 全球市佔率分析（2025 年）
  • 公司簡介
    • Siemens
    • Sartorius AG
    • Danaher Corporation（Cytiva）
    • Emerson Electric Co.
    • Korber AG.
    • Aspen Technology
    • Benchling
    • TetraScience, Inc.
    • Schneider Electric
    • Other Prominent Players
Product Code: FBI117444

Growth Factors of digital biomanufacturing Market

The global digital biomanufacturing market was valued at USD 22.44 billion in 2025 and is projected to grow to USD 25.16 billion in 2026. The market is expected to reach USD 66.14 billion by 2034, expanding at a CAGR of 12.84% during the forecast period. The increasing production of biologics, biosimilars, vaccines, cell therapies, and gene therapies, coupled with rising demand for automation and digital process optimization, is driving market expansion. In 2025, North America dominated the digital biomanufacturing market, accounting for 41.27% of the global market share.

Digital biomanufacturing combines automation, connected equipment, process analytics, manufacturing execution systems (MES), electronic batch records (eBR), artificial intelligence, and real-time monitoring to optimize biologics manufacturing. The growing adoption of single-use technologies, increasing outsourcing to contract development and manufacturing organizations (CDMOs), and the transition from paper-based documentation to connected digital workflows continue to accelerate market growth worldwide.

Market Trends

A major trend in the digital biomanufacturing market is the growing adoption of automation and real-time process control. Biopharmaceutical manufacturers are replacing manual production methods with integrated digital platforms capable of monitoring critical process parameters such as pH, dissolved oxygen, temperature, pressure, and feed rates in real time.

The integration of SCADA systems, distributed control systems (DCS), process analytical technology (PAT), cloud platforms, and AI-driven monitoring tools is improving manufacturing consistency, reducing batch failures, and accelerating technology transfer across development and commercial production facilities.

Market Drivers

The rapid expansion of biologics, biosimilars, vaccines, recombinant proteins, cell therapies, and gene therapies remains the primary growth driver for the digital biomanufacturing market. Unlike conventional pharmaceutical manufacturing, biologics production requires highly controlled, data-intensive manufacturing environments with strict regulatory compliance.

Digital manufacturing platforms help reduce manual errors, improve batch consistency, simplify regulatory documentation, accelerate process scale-up, and enhance technology transfer across multiple manufacturing sites. Increasing investments by CDMOs and biopharmaceutical companies in advanced manufacturing facilities continue supporting strong market growth.

Market Restraints

High implementation costs remain a major challenge for digital biomanufacturing adoption. Deploying integrated digital manufacturing systems requires significant investments in automation infrastructure, MES, electronic batch records, process analytical technologies, cybersecurity, data integration, validation, employee training, and ongoing technical support.

Smaller biotechnology companies and regional manufacturers often adopt digital technologies gradually because of budget limitations and the complexity of integrating modern platforms with existing legacy systems.

Market Opportunities

Growing regulatory support for advanced pharmaceutical manufacturing presents significant growth opportunities for the industry. Regulatory agencies increasingly encourage the adoption of automation, digital twins, robotics, AI, and real-time monitoring technologies that improve manufacturing consistency and product quality.

The increasing commercialization of advanced therapies, including cell and gene therapies, is creating strong demand for digitally connected manufacturing platforms capable of delivering scalable, validated, and regulatory-compliant production environments.

Market Challenges

A shortage of skilled professionals with expertise in both bioprocess engineering and digital manufacturing technologies remains one of the industry's key challenges. Successful implementation requires specialists experienced in automation, artificial intelligence, MES, process analytical technology, data integration, validation, cybersecurity, and quality management.

The limited availability of qualified personnel increases implementation costs, delays deployment schedules, and slows the realization of productivity improvements following digital investments.

Segmentation Analysis

Based on offering, the hardware and connected equipment segment dominated the market in 2025 due to substantial investments in automated bioreactors, connected single-use systems, and integrated manufacturing equipment. Meanwhile, the services segment is expected to witness the fastest growth as companies increasingly require consulting, validation, system integration, and technical support.

By type, the automation and process control segment holds the largest market share because biologics manufacturing depends heavily on continuous monitoring and control of critical production parameters. The AI, machine learning, and advanced analytics segment is projected to record the highest growth throughout the forecast period.

According to application, commercial GMP manufacturing execution remains the dominant segment as manufacturers increasingly adopt paperless batch records, automated production workflows, and regulatory-compliant manufacturing systems. Technology transfer and facility digitalization are also expanding rapidly as companies modernize production facilities.

By end user, pharmaceutical and biotechnology companies account for the largest market share due to significant investments in biologics manufacturing capacity, digital transformation, and global production expansion. Contract manufacturing organizations (CMOs) and CDMOs are also experiencing strong demand as outsourcing continues to grow.

Regional Outlook

North America led the global digital biomanufacturing market in 2025, generating USD 9.26 billion in revenue. The region benefits from extensive biologics manufacturing capacity, advanced automation technologies, strong regulatory support, and widespread adoption of digital manufacturing platforms. The U.S. market is projected to reach USD 9.42 billion in 2026, representing approximately 37.5% of global revenue.

Europe remains the second-largest market, supported by established biologics manufacturing infrastructure, increasing adoption of digital manufacturing systems, and favorable regulatory policies.

Asia Pacific is expected to experience the fastest growth, reaching USD 5.70 billion in 2026. Rapid expansion of biologics manufacturing, CDMO capacity, vaccines, biosimilars, and advanced therapies across China, India, Japan, South Korea, Singapore, and Australia continues driving regional demand.

Meanwhile, Latin America and the Middle East & Africa are witnessing steady market expansion through increasing investments in pharmaceutical manufacturing, healthcare infrastructure, and local biologics production.

Competitive Landscape

The digital biomanufacturing market remains moderately fragmented, with major companies focusing on integrated automation platforms, cloud-based manufacturing systems, AI-driven analytics, digital twins, and connected laboratory informatics. Leading industry participants include Siemens, Sartorius AG, Danaher Corporation (Cytiva), Emerson Electric Co., Korber AG, Aspen Technology, Benchling, TetraScience, Schneider Electric, and Rockwell Automation. Strategic partnerships, portfolio expansion, and technological innovation continue to strengthen competitive positioning across the global market.

Conclusion

The global digital biomanufacturing market is expected to grow significantly from USD 22.44 billion in 2025 to USD 25.16 billion in 2026, reaching USD 66.14 billion by 2034. Increasing production of biologics, biosimilars, vaccines, and advanced therapies, together with rising adoption of automation, artificial intelligence, and connected manufacturing systems, will continue driving market growth. Although implementation costs and workforce shortages remain key challenges, ongoing technological advancements, regulatory support, and expanding digital transformation across biopharmaceutical manufacturing are expected to create substantial long-term growth opportunities throughout the forecast period.

Segmentation By Offering, Type, Application, End User, and Region

By Offering * Software & Platforms

  • Hardware & Connected Equipment
  • Services

By Type * Manufacturing Execution & Electronic Batch Records

  • Automation & Process Control
  • Process Analytical Technology & Real-time Monitoring
  • Digital Twins, Modeling & Simulation
  • AI, Machine Learning & Advanced Analytics
  • Bioprocess Data Management & Integration
  • Quality & Laboratory Informatics
  • Others

By Application * Process Development & Scale-up

  • Commercial GMP Manufacturing Execution
  • Real-time Process Monitoring & Control
  • Quality Management & Batch Release
  • Technology Transfer & Facility Digitalization
  • Others

By End User * Pharmaceuticals & Biotechnology Companies

  • Academic & Research Institutes
  • CMOs & CDMOs
  • Others

By Region * North America (By Offering, Type, Application, End User, and Country)

    • U.S.
    • Canada
  • Europe (By Offering, Type, Application, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Offering, Type, Application, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Offering, Type, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Type, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends
  • 3.5. Market Challenges

4. Key Insights

  • 4.1. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
  • 4.2. New Product Launches, By Key Players
  • 4.3. Overview: Investment Trends in Digital Biomanufacturing
  • 4.4. Technological Advances in Digital Biomanufacturing

5. Global Digital Biomanufacturing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offering
    • 5.1.1. Software & Platforms
    • 5.1.2. Hardware & Connected Equipment
    • 5.1.3. Services
  • 5.2. Market Analysis, Insights and Forecast - By Type
    • 5.2.1. Manufacturing Execution & Electronic Batch Records
    • 5.2.2. Automation & Process Control
    • 5.2.3. Process Analytical Technology & Real-time Monitoring
    • 5.2.4. Digital Twins, Modelling & Simulation
    • 5.2.5. AI, Machine Learning & Advanced Analytics
    • 5.2.6. Bioprocess Data Management & Integration
    • 5.2.7. Quality & Laboratory Informatics
    • 5.2.8. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Process Development & Scale-up
    • 5.3.2. Commercial GMP Manufacturing Execution
    • 5.3.3. Real-time Process Monitoring & Control
    • 5.3.4. Quality Management & Batch Release
    • 5.3.5. Technology Transfer & Facility Digitalization
    • 5.3.6. Others
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Pharmaceuticals & Biotechnology Companies
    • 5.4.2. Academic & Research Institutes
    • 5.4.3. CMOs & CDMOs
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Digital Biomanufacturing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offering
    • 6.1.1. Software & Platforms
    • 6.1.2. Hardware & Connected Equipment
    • 6.1.3. Services
  • 6.2. Market Analysis, Insights and Forecast - By Type
    • 6.2.1. Manufacturing Execution & Electronic Batch Records
    • 6.2.2. Automation & Process Control
    • 6.2.3. Process Analytical Technology & Real-time Monitoring
    • 6.2.4. Digital Twins, Modelling & Simulation
    • 6.2.5. AI, Machine Learning & Advanced Analytics
    • 6.2.6. Bioprocess Data Management & Integration
    • 6.2.7. Quality & Laboratory Informatics
    • 6.2.8. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Process Development & Scale-up
    • 6.3.2. Commercial GMP Manufacturing Execution
    • 6.3.3. Real-time Process Monitoring & Control
    • 6.3.4. Quality Management & Batch Release
    • 6.3.5. Technology Transfer & Facility Digitalization
    • 6.3.6. Others
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Pharmaceuticals & Biotechnology Companies
    • 6.4.2. Academic & Research Institutes
    • 6.4.3. CMOs & CDMOs
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Digital Biomanufacturing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offering
    • 7.1.1. Software & Platforms
    • 7.1.2. Hardware & Connected Equipment
    • 7.1.3. Services
  • 7.2. Market Analysis, Insights and Forecast - By Type
    • 7.2.1. Manufacturing Execution & Electronic Batch Records
    • 7.2.2. Automation & Process Control
    • 7.2.3. Process Analytical Technology & Real-time Monitoring
    • 7.2.4. Digital Twins, Modelling & Simulation
    • 7.2.5. AI, Machine Learning & Advanced Analytics
    • 7.2.6. Bioprocess Data Management & Integration
    • 7.2.7. Quality & Laboratory Informatics
    • 7.2.8. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Process Development & Scale-up
    • 7.3.2. Commercial GMP Manufacturing Execution
    • 7.3.3. Real-time Process Monitoring & Control
    • 7.3.4. Quality Management & Batch Release
    • 7.3.5. Technology Transfer & Facility Digitalization
    • 7.3.6. Others
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Pharmaceuticals & Biotechnology Companies
    • 7.4.2. Academic & Research Institutes
    • 7.4.3. CMOs & CDMOs
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Digital Biomanufacturing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offering
    • 8.1.1. Software & Platforms
    • 8.1.2. Hardware & Connected Equipment
    • 8.1.3. Services
  • 8.2. Market Analysis, Insights and Forecast - By Type
    • 8.2.1. Manufacturing Execution & Electronic Batch Records
    • 8.2.2. Automation & Process Control
    • 8.2.3. Process Analytical Technology & Real-time Monitoring
    • 8.2.4. Digital Twins, Modelling & Simulation
    • 8.2.5. AI, Machine Learning & Advanced Analytics
    • 8.2.6. Bioprocess Data Management & Integration
    • 8.2.7. Quality & Laboratory Informatics
    • 8.2.8. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Process Development & Scale-up
    • 8.3.2. Commercial GMP Manufacturing Execution
    • 8.3.3. Real-time Process Monitoring & Control
    • 8.3.4. Quality Management & Batch Release
    • 8.3.5. Technology Transfer & Facility Digitalization
    • 8.3.6. Others
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Pharmaceuticals & Biotechnology Companies
    • 8.4.2. Academic & Research Institutes
    • 8.4.3. CMOs & CDMOs
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. China
    • 8.5.2. Japan
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Digital Biomanufacturing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offering
    • 9.1.1. Software & Platforms
    • 9.1.2. Hardware & Connected Equipment
    • 9.1.3. Services
  • 9.2. Market Analysis, Insights and Forecast - By Type
    • 9.2.1. Manufacturing Execution & Electronic Batch Records
    • 9.2.2. Automation & Process Control
    • 9.2.3. Process Analytical Technology & Real-time Monitoring
    • 9.2.4. Digital Twins, Modelling & Simulation
    • 9.2.5. AI, Machine Learning & Advanced Analytics
    • 9.2.6. Bioprocess Data Management & Integration
    • 9.2.7. Quality & Laboratory Informatics
    • 9.2.8. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Process Development & Scale-up
    • 9.3.2. Commercial GMP Manufacturing Execution
    • 9.3.3. Real-time Process Monitoring & Control
    • 9.3.4. Quality Management & Batch Release
    • 9.3.5. Technology Transfer & Facility Digitalization
    • 9.3.6. Others
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Pharmaceuticals & Biotechnology Companies
    • 9.4.2. Academic & Research Institutes
    • 9.4.3. CMOs & CDMOs
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Digital Biomanufacturing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offering
    • 10.1.1. Software & Platforms
    • 10.1.2. Hardware & Connected Equipment
    • 10.1.3. Services
  • 10.2. Market Analysis, Insights and Forecast - By Type
    • 10.2.1. Manufacturing Execution & Electronic Batch Records
    • 10.2.2. Automation & Process Control
    • 10.2.3. Process Analytical Technology & Real-time Monitoring
    • 10.2.4. Digital Twins, Modelling & Simulation
    • 10.2.5. AI, Machine Learning & Advanced Analytics
    • 10.2.6. Bioprocess Data Management & Integration
    • 10.2.7. Quality & Laboratory Informatics
    • 10.2.8. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Process Development & Scale-up
    • 10.3.2. Commercial GMP Manufacturing Execution
    • 10.3.3. Real-time Process Monitoring & Control
    • 10.3.4. Quality Management & Batch Release
    • 10.3.5. Technology Transfer & Facility Digitalization
    • 10.3.6. Others
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Pharmaceuticals & Biotechnology Companies
    • 10.4.2. Academic & Research Institutes
    • 10.4.3. CMOs & CDMOs
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Siemens
    • 11.2.2. Sartorius AG
    • 11.2.3. Danaher Corporation (Cytiva)
    • 11.2.4. Emerson Electric Co.
    • 11.2.5. Korber AG.
    • 11.2.6. Aspen Technology
    • 11.2.7. Benchling
    • 11.2.8. TetraScience, Inc.
    • 11.2.9. Schneider Electric
    • 11.2.10. Other Prominent Players

List of Tables

  • Table 1: Global Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 2: Global Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 3: Global Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 4: Global Digital Biomanufacturing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 5: Global Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 6: North America Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 7: North America Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 8: North America Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 9: North America Digital Biomanufacturing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 10: North America Digital Biomanufacturing Market Revenue (USD billion) Forecast, by Country, 2021-2034
  • Table 11: Europe Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 12: Europe Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 13: Europe Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 14: Europe Digital Biomanufacturing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 15: Europe Digital Biomanufacturing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 17: Asia Pacific Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 18: Asia Pacific Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: Asia Pacific Digital Biomanufacturing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 20: Asia Pacific Digital Biomanufacturing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 21: Latin America Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 22: Latin America Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 23: Latin America Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 24: Latin America Digital Biomanufacturing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 25: Latin America Digital Biomanufacturing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Offering, 2021-2034
  • Table 27: Middle East & Africa Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Type, 2021-2034
  • Table 28: Middle East & Africa Digital Biomanufacturing Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 29: Middle East & Africa Digital Biomanufacturing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 30: Middle East & Africa Digital Biomanufacturing Market Revenue (USD billion) Forecast, by Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Digital Biomanufacturing Market Revenue Breakdown (USD billion, %) By Region, 2025 & 2034
  • Figure 2: Global Digital Biomanufacturing Market Value Share (%), By Offering, 2025 & 2034
  • Figure 3: Global Digital Biomanufacturing Market Value Share (%), By Type, 2025 & 2034
  • Figure 4: Global Digital Biomanufacturing Market Value Share (%), By Application, 2025 & 2034
  • Figure 5: Global Digital Biomanufacturing Market Value Share (%), By End User, 2025 & 2034
  • Figure 6: Global Digital Biomanufacturing Market Value Share (%), By Region, 2025 & 2034
  • Figure 7: North America Digital Biomanufacturing Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 8: North America Digital Biomanufacturing Market Value Share (%), By Offering, 2025
  • Figure 9: North America Digital Biomanufacturing Market Value (USD billion), By Type, 2025 & 2034
  • Figure 10: North America Digital Biomanufacturing Market Value Share (%), By Type, 2025
  • Figure 11: North America Digital Biomanufacturing Market Value (USD billion), By Application, 2025 & 2034
  • Figure 12: North America Digital Biomanufacturing Market Value Share (%), By Application, 2025
  • Figure 13: North America Digital Biomanufacturing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 14: North America Digital Biomanufacturing Market Value Share (%), By End User, 2025
  • Figure 15: North America Digital Biomanufacturing Market Value (USD billion), by Country, 2025 & 2034
  • Figure 16: North America Digital Biomanufacturing Market Value Share (%), by Country, 2025
  • Figure 17: Europe Digital Biomanufacturing Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 18: Europe Digital Biomanufacturing Market Value Share (%), By Offering, 2025
  • Figure 19: Europe Digital Biomanufacturing Market Value (USD billion), By Type, 2025 & 2034
  • Figure 20: Europe Digital Biomanufacturing Market Value Share (%), By Type, 2025
  • Figure 21: Europe Digital Biomanufacturing Market Value (USD billion), By Application, 2025 & 2034
  • Figure 22: Europe Digital Biomanufacturing Market Value Share (%), By Application, 2025
  • Figure 23: Europe Digital Biomanufacturing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 24: Europe Digital Biomanufacturing Market Value Share (%), By End User, 2025
  • Figure 25: Europe Digital Biomanufacturing Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Digital Biomanufacturing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Digital Biomanufacturing Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 28: Asia Pacific Digital Biomanufacturing Market Value Share (%), By Offering, 2025
  • Figure 29: Asia Pacific Digital Biomanufacturing Market Value (USD billion), By Type, 2025 & 2034
  • Figure 30: Asia Pacific Digital Biomanufacturing Market Value Share (%), By Type, 2025
  • Figure 31: Asia Pacific Digital Biomanufacturing Market Value (USD billion), By Application, 2025 & 2034
  • Figure 32: Asia Pacific Digital Biomanufacturing Market Value Share (%), By Application, 2025
  • Figure 33: Asia Pacific Digital Biomanufacturing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 34: Asia Pacific Digital Biomanufacturing Market Value Share (%), By End User, 2025
  • Figure 35: Asia Pacific Digital Biomanufacturing Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Digital Biomanufacturing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 37: Latin America Digital Biomanufacturing Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 38: Latin America Digital Biomanufacturing Market Value Share (%), By Offering, 2025
  • Figure 39: Latin America Digital Biomanufacturing Market Value (USD billion), By Type, 2025 & 2034
  • Figure 40: Latin America Digital Biomanufacturing Market Value Share (%), By Type, 2025
  • Figure 41: Latin America Digital Biomanufacturing Market Value (USD billion), By Application, 2025 & 2034
  • Figure 42: Latin America Digital Biomanufacturing Market Value Share (%), By Application, 2025
  • Figure 43: Latin America Digital Biomanufacturing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 44: Latin America Digital Biomanufacturing Market Value Share (%), By End User, 2025
  • Figure 45: Latin America Digital Biomanufacturing Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Digital Biomanufacturing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Digital Biomanufacturing Market Value (USD billion), By Offering, 2025 & 2034
  • Figure 48: Middle East & Africa Digital Biomanufacturing Market Value Share (%), By Offering, 2025
  • Figure 49: Middle East & Africa Digital Biomanufacturing Market Value (USD billion), By Type, 2025 & 2034
  • Figure 50: Middle East & Africa Digital Biomanufacturing Market Value Share (%), By Type, 2025
  • Figure 51: Middle East & Africa Digital Biomanufacturing Market Value (USD billion), By Application, 2025 & 2034
  • Figure 52: Middle East & Africa Digital Biomanufacturing Market Value Share (%), By Application, 2025
  • Figure 53: Middle East & Africa Digital Biomanufacturing Market Value (USD billion), By End User, 2025 & 2034
  • Figure 54: Middle East & Africa Digital Biomanufacturing Market Value Share (%), By End User, 2025
  • Figure 55: Middle East & Africa Digital Biomanufacturing Market Value (USD billion), by Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Digital Biomanufacturing Market Value Share (%), by Country/ Sub-region, 2025
  • Figure 57: Global Digital Biomanufacturing Market Share (%), by Company, 2025